Therapeutic Asset Ratings
1,583 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
DEXKETOPROFEN
Mild Cognitive Impairment
Zi-Xiao Li
Early P1
CCC
(51)
GLUCOSE, ANHYDROUS
Cystic Fibrosis-related Diabetes
Children's Hospital of Philadelphia
Early P1
CCC
(51)
METAMIZOLE
Mild Cognitive Impairment
Zi-Xiao Li
Early P1
CCC
(51)
NEPENTHE
Mild Cognitive Impairment
Zi-Xiao Li
Early P1
CCC
(51)
ROPIVACAINE
Chronic Postoperative Pain
Xijing Hospital
Early P1
CCC
(51)
Hyaluronidase
Pain, Chronic
Minia University
Early P1
CCC
(49)
rd13-02 cell infusion
Hematologic Neoplasms
Kai Lin Xu，MD
Early P1
CCC
(48)
Acetylsalicylic Acid
Colorectal Neoplasms
University of Michigan Rogel Cancer Center
Early P1
CC
(47)
GLUCOSE, ANHYDROUS
Cystic Fibrosis
Children's Hospital of Philadelphia
Early P1
CC
(47)
rd13-02 cell infusion
Hematologic Diseases
Kai Lin Xu，MD
Early P1
CC
(47)
ZOPICLONE
Insomnia
Salem Anaesthesia Pain Clinic
Early P1
CC
(47)
cs-101
Beta-Thalassemia
Children's Hospital of Fudan University
Early P1
CC
(45)
LEVODOPA
Healthy Volunteers
University of Minnesota
Early P1
CC
(45)
[14c]-rencofilstat
NASH With Fibrosis
Hepion Pharmaceuticals, Inc.
Early P1
CC
(43)
177lu-ctr-fapi
Metastatic Solid Tumors (Any Localization)
Lanzhou University Second Hospital
Early P1
CC
(43)
[177Lu]Lu-TEFAPI-06
Metastatic Solid Tumors (Any Localization)
Lanzhou University Second Hospital
Early P1
CC
(43)
5-azacytidine
Calcification
City of Hope Medical Center
Early P1
CC
(43)
[68ga] mdm2/mdmx peptide
MDM2/MDMX Gene Mutation
Peking University Cancer Hospital & Institute
Early P1
CC
(43)
[68ga] mdm2/mdmx peptide
Nuclear Medicine
Peking University Cancer Hospital & Institute
Early P1
CC
(43)
[68ga] mdm2/mdmx peptide
Positron Emission Tomography Imaing
Peking University Cancer Hospital & Institute
Early P1
CC
(43)
68ga-nodaga-sna009
GPA33
SmartNuclide Biopharma
Early P1
CC
(43)
ADVICOR COMPONENT NIACIN
Type 2 Diabetes
Université de Sherbrooke
Early P1
CC
(43)
AK 127
Advanced or Metastatic Solid Tumours
Akesobio Australia Pty Ltd
Early P1
CC
(43)
Bazedoxifene
Increased Risk for Development of Breast Cancer
Carol Fabian, MD
Early P1
CC
(43)
CANNABIVAROL, .DELTA.9-TETRAHYDRO-
Hypercholesterolemia
Medical Life Care Planners, LLC
Early P1
CC
(43)
Showing 1 to 25 of 1,583 assets
Previous
Page 1 of 64
Next
